Company: YSXT
Filing Date: 2025-07-31
Form Type: 20-F
Source: 0001410578-25-001545
Chunk: 156

Company: YSX Tech Co., Ltd
Filing Date: 2025-07-31
Form: 20-F
Item: Item 6
Chunk 156
---
 degree in Economic Law from Jiangxi University of Finance and Economics in 2013.

Meng Caohas served as our independent director since December 2024. Since January 2019, Mr. Meng Cao has served as the general manager at Shenzhen Canyu E-Commerce Co., Ltd. Since August 2020, he has served as a director at Guilishi Medical Beauty Hospital Co., Ltd. Since May 2022, he has served as a financial director at Guangzhou Hanyishen Medical Co., Ltd. Since March 2023, he has served as a director at Guangzhou Senyuanzhang Digital Technology Co., Ltd. He received a Bachelor’s degree in international economics and Trade in 2011, and a Master’s degree in International Economics and Trade in 2013, from Chungwoon University in Korea.

Family Relationships

Jie Xiao and Geran Xiao are cousins. None of our other directors or executive officers have a family relationship as defined in Item 401 of Regulation S-K.

Controlled Company

As of the date of this annual report, Mr. Jie Xiao, our CEO and chairman of the board of directors, beneficially owns approximately 56.50% of the aggregate voting power of our issued and outstanding Class A Ordinary Shares and Class B Ordinary Shares as a group. As a result, we are a “controlled company” for the purpose of the Nasdaq listing rules. As a controlled company, we are permitted to elect to rely on certain exemptions from the obligations to comply with certain corporate governance requirements, including:

  the requirement that our director nominees be selected or recommended solely by independent directors; and  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────

  the requirement that we have a nominating and corporate governance committee and a compensation committee that are composed entirely of independent directors with a written charter addressing t...  

Although we do not intend to rely on the controlled company exemptions under the Nasdaq listing rules, we could elect to rely on these exemptions in the future, and if so, you would not have the same protection afforded to shareholders of companies that are subject to all of the corporate governance requirements of Nasdaq.

B. Compensation

For the fiscal year ended March 31, 2025, we and the operating entities paid an aggregate of $109,234 (RMB 788,328) as compensation to our executive officers and directors. Neither the Company nor the operating entities have set aside or accrued any amount to provide